Interpretation and implications of the prematurely terminated stenting and aggressive medical management for preventing recurrent stroke in the intracranial stenosis (SAMMPRIS) trial

Neurosurgery

Volumn 70, Issue 1, 2012, Pages

  Qureshi, Adnan I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NITINOL; PROBUCOL;

ANEURYSM; ANGIOGRAPHY; ANGIOPLASTY; ATHEROSCLEROSIS; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; DISEASE SEVERITY; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; HUMAN; INTRACRANIAL STENOSIS; LETTER; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; STENOSIS; STENT; STENT THROMBOSIS; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; CONSTRICTION, PATHOLOGIC; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION; STENTS; STROKE;

EID: 84856119752     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e318239f318     Document Type: Letter

References (50)

1. Derdeyn CP, Chimowitz MI. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am. 2007;17(3):355-363; viii-ix. (Pubitemid 47362743)
2. Qureshi AI, Hutson AD, Harbaugh RE, Stieg PE, Hopkins LN. Methods and design considerations for randomized clinical trials evaluating surgical or endovascular treatments for cerebrovascular diseases. Neurosurgery. 2004;54(2): 248-264; discussion 264-247.
3. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke. 2004;35(6): 1388-1392.
4. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke. 2007;38(5):1531-1537. (Pubitemid 46684170)
5. Jiang WJ, Xu XT, Jin M, Du B, Dong KH, Dai JP. Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. AJNR Am J Neuroradiol. 2007; 28(5):830-834. (Pubitemid 46776056)
6. Suri MF, Tariq N, Siddiq F, et al. Intracranial angioplasty and/or stent placement in octogenarians is associated with a threefold greater risk of periprocedural stroke or death. J Endovasc Ther. 2010;17(3):314-319.
7. Nahab F, Lynn MJ, Kasner SE, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology. 2009;72(23):2014-2019.
8. Kurre W, Berkefeld J, Brassel F, et al. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRA-STENT multicentric registry. Stroke. 2010;41(3):494-498.
9. Qureshi AI, Tariq N, Hassan AE, et al. Predictors and timing of neurological complications following intracranial angioplasty and/or stent placement. Neuro-surgery. 2011;68(1):53-60; discussion 60-51.
10. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008;70(17):1518-1524. (Pubitemid 351589505)
11. Gupta R, Schumacher HC, Mangla S, et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology. 2003;61(12): 1729-1735. (Pubitemid 38020820)
12. Levy EI, Siddiqui AH, Crumlish A, et al. First food and drug administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke. 2009;40(11):3552-3556.
13. Jiang WJ, Xu XT, Du B, et al. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology. 2007;68(6):420-426. (Pubitemid 46208744)
14. Groschel K, Schnaudigel S, Pilgram SM, Wasser K, Kastrup A. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke. 2009;40(5): e340-347.
15. Jiang WJ, Du B, Leung TW, Xu XT, Jin M, Dong KH. Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement. Radiology. 2007;243(1):188-197. (Pubitemid 46579710)
16. Schumacher HC, Meyers PM, Higashida RT, et al. Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis. Stroke. 2009;40(5):e348-365.
17. Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke. 2004;35(6):1375-1380. (Pubitemid 38697461)
18. Qureshi AI, Suri MF, Siddiqui AM, et al. Clinical and angiographic results of dilatation procedures for symptomatic intracranial atherosclerotic disease. J Neuroimaging. 2005;15(3):240-249. (Pubitemid 40863658)
19. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38(3):881-887. (Pubitemid 46568447)
20. Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery. 2007;61(2):236-242; discussion 242-233. (Pubitemid 47357287)
21. Siddiq F, Vazquez G, Memon MZ, et al. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke. 2008;39(9):2505-2510.
22. Siddiq F, Memon MZ, Vazquez G, Safdar A, Qureshi AI. Comparison between primary angioplasty and stent placement for symptomatic intracranial atheroscle¬rotic disease: meta-analysis of case series. Neurosurgery. 2009;65:1024-1033; discussion 1033-1024.
23. Nguyen TN, Zaidat OO, Gupta R, et al. Balloon angioplasty for intracranial atherosclerotic disease: periprocedural risks and short-term outcomes in a multi-center study. Stroke. 2011;42(1):107-111.
24. Popma JJ, Ohman EM, Weitz J, Lincoff AM, Harrington RA, Berger P. Antithrombotic therapy in patients undergoing percutaneous coronary interven¬tion. Chest. 2001;119(1 suppl):S321-S336.
25. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113(7):e166-286. (Pubitemid 43879461)
26. Briggs C, Hyde K, Mackie I, Parker N, Popek M, Porter N. Guidelines for point-of-care testing: haematology. Br J Haematol. 2008;142(6):904-915.
27. Paniccia R, Fedi S, Carbonetto F, et al. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test. Anesthesiology. 2003;99(1):54-59. (Pubitemid 36799033)
28. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355:1660-1671. (Pubitemid 44583956)
29. Brott TG, Hobson RW II, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11-23.
30. Hopkins LN, Roubin GS, Chakhtoura EY, et al. The carotid revascularization endarterectomy versus stenting trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis. 2010;19(2):153-162.
31. Qureshi AI, Abou-Chebl A, Jovin TG. Qualification requirements for performing neurointerventional procedures: a Report of the Practice Guidelines Committee of the American Society of Neuroimaging and the Society of Vascular and Interventional Neurology. J Neuroimaging. 2008;18(4):433-447.
32. Connors JJ III, Sacks D, Furlan AJ, et al. Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, American Association of Neurological Surgeons, American Society of Interventional and Therapeutic Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, AANS/CNS Cerebrovascular Section, and Society of Interventional Radiology. Radiology. 2005;234(1):26-34. (Pubitemid 40003779)
33. Higashida RT, Meyers PM, Connors JJ, et al. Intracranial angioplasty & stenting for cerebral atherosclerosis: a position statement of the American Society of Interven-tional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. J Vasc Interv Radiol. 2005;16(10):1281-1285. (Pubitemid 41463984)
34. Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scien¬tific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2009;119(16):2235-2249.
35. Qureshi AI, Feldmann E, Gomez CR, et al. Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging. 2009; 19(suppl 1):1S-10S.
36. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(1):227-276.
37. Endovascular Stent Insertion for Intracranial Atherosclerotic Disease. London, United Kingdom: National Institute for Health and Clinical Excellence; 2007.
38. NEUROLINK System-H010004. Santa Clara, CA: Guidant Corporation; 2009.
39. Proposed Decision Memorandum for Intracranial Stenting and Angioplasty. Baltimore, MD: CMS; 2008.
40. Services DoHaH. Federal Register. 2006.
41. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352(13): 1305-1316.
42. Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 2006;66(8): 1187-1191. (Pubitemid 43739702)
43. Kent KM, Bentivoglio LG, Block PC, et al. Percutaneous transluminal coronary angioplasty: report from the registry of the National Heart, Lung, and Blood Institute. Am J Cardiol. 1982;49(8):2011-2020. (Pubitemid 12059059)
44. Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. N Engl J Med. 1988;318(5):265-270. (Pubitemid 18034516)
45. Schatz RA, Baim DS, Leon M, et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation. 1991;83(1):148-161.
46. Pepine CJ, Holmes DR Jr. Coronary artery stents. American College of Cardiology. J Am Coll Cardiol. 1996;28(3):782-794.
47. Oesterle SN, Whitbourn R, Fitzgerald PJ, et al. The stent decade: 1987 to 1997. Stanford stent summit faculty. Am Heart J. 1998;136(4 pt 1):578-599. (Pubitemid 28483499)
48. Qureshi AI, Janardhan V, Memon MZ, et al. Initial experience in establishing an academic neuroendovascular service: program building, procedural types, and outcomes. J Neuroimaging. 2009;19(1):72-79.
49. Leifer D, Bravata DM, Connors JJ III, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to brain attack coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(3):849-877.
50. Palesch YY, Tilley BC, Sackett DL, Johnston KC, Woolson R. Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005;36(11):2410-2414. (Pubitemid 41566968)